Belladonna and Opium Suppositories CII
Generic Name and Formulations:
Belladonna extract (powdered), opium (powdered); 16.2mg/30mg, 16.2mg/60mg.
Indications for Belladonna and Opium Suppositories:
Moderate to severe pain associated with ureteral spasms.
1 supp rectally once or twice daily; max 4 doses/day.
Glaucoma. Severe hepatic or renal disease. Asthma. Narcotic idiosyncrasies. Respiratory depression. Convulsive disorders. Acute alcoholism. Delirium tremens. Premature labor.
Idiosyncrasies to atropine and related drugs. Cardiac disease. Incipient glaucoma. GI or GU obstruction. Increased intracranial pressure. Toxic psychosis. Myxedema. Drug abusers. Elderly. Debilitated. Pregnancy (Cat.C). Nursing mothers.
Antispasmodic + opioid.
CNS effects potentiated with alcohol, other CNS depressants, MAOIs, tricyclic antidepressants, anticholinergics. Potentiated by anticholinergics.
Drowsiness, anticholinergic effects (eg, dry mouth, urinary retention, dizziness, blurred vision, constipation), photophobia, tachycardia, GI upset, pruritus, urticaria.
Formerly known under the brand name B&O Supprettes 15A, B&O Supprettes 16A.
Endocrinology Advisor Articles
- Testosterone Use Remains High Among Men With Coronary Artery Disease
- Primary Characteristics of PCOS Predictive of Obstetric Complications
- Comparing Osteoporosis Screening, Treatment Strategies in Postmenopausal Women
- Maternal Thyroid Function in Pregnancy Linked to Childhood Risk for Disease
- Cerebral Small Vessel Disease More Common in Individuals With T1D vs General Population
- ADA's 2019 Standards of Medical Care in Diabetes Focus on Patient-Centered Care
- Sleep Habits Affect Insulin Sensitivity in Adolescents With Overweight, Obesity
- Levothyroxine Associated With Increased Mortality in Patients With Heart Failure
- Head-to-Head Comparison of Professional vs Personal CGM Systems in T1D
- Dual vs Triple Therapy for Metformin Treatment Intensification in Type 2 Diabetes
- Insulin Analogs vs Regular Human Insulin for Type 2 Diabetes
- Diabetic Ketoacidosis May Affect Brain Development in Children With T1D
- Higher Rates of Comorbidities Among Holocaust Survivors
- Population Health Data May Help Identify Patients at Risk for CVD
- Newborn Genomic Sequencing Can Identify Disease Risk